Raging Capital Management’s Pacific Biosciences PACB Stock Holding History

Raging Capital Management’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,316,614	Closed	-$6.8M	–	29
2018 Q1	$6.8M	Buy	3,316,614 +125,519	+4%	+$326K	0.91%	27
2017 Q4	$8.42M	Sell	3,191,095 -1,232,968	-28%	-$4.32M	1.14%	28
2017 Q3	$23.2M	Sell	4,424,063 -710,937	-14%	-$3.06M	3.61%	9
2017 Q2	$18.3M	Buy	5,135,000 +193,288	+4%	+$779K	3.44%	14
2017 Q1	$25.5M	Buy	+4,941,712	New	+$24.2M	2.63%	15
2016 Q4	–	Sell	-2,818,004	Closed	-$25.2M	–	63
2016 Q3	$25.2M	Buy	2,818,004 +1,073,108	+61%	+$8.97M	3.48%	10
2016 Q2	$12.3M	Buy	+1,744,896	New	+$15.9M	1.89%	21
2015 Q4	–	Sell	-1,566,056	Closed	-$5.73M	–	46
2015 Q3	$5.73M	Buy	+1,566,056	New	+$7.66M	0.75%	26
2014 Q4	–	Sell	-1,579,097	Closed	-$7.75M	–	50
2014 Q3	$7.75M	Sell	1,579,097 -30,978	-2%	-$162K	0.87%	30
2014 Q2	$9.95M	Buy	1,610,075 +606,928	+61%	+$3.04M	1.06%	24
2014 Q1	$5.37M	Sell	1,003,147 -259,119	-21%	-$1.64M	0.95%	29
2013 Q4	$6.6M	Buy	1,262,266 +252,200	+25%	+$1.16M	1.21%	27
2013 Q3	$5.58M	Sell	1,010,066 -25,000	-2%	-$86.8K	0.96%	30
2013 Q2	$2.62M	Buy	+1,035,066	New	+$2.58M	0.69%	31

Other funds holding PACB

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Raging Capital Management's PACB Position: Q2 2018 in Review

Raging Capital Management sold out of Pacific Biosciences (PACB) in Q2 2018, closing a stake of 3,316,614 shares — an estimated $6.8M sold.

Raging Capital Management first reported a position in PACB in Q2 2013 and held it in 14 quarters. The position peaked at $25.5M in Q1 2017. 99 funds tracked by Wall St. Rank hold PACB as of Q2 2018.

Raging Capital Management reported no remaining Pacific Biosciences position as of Q2 2018 after selling out during the quarter.
Raging Capital Management sold 3,316,614 Pacific Biosciences shares in Q2 2018, an estimated $6.8M.
Raging Capital Management first reported a position in Pacific Biosciences in Q2 2013 and held it in 14 quarters.
Raging Capital Management's Pacific Biosciences position peaked at $25.5M in Q1 2017.
99 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2018.

Based on Raging Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.